The downregulation of tyrosine metabolism pathway-related genes (HPD, HGD, GSTZ1, and FAH) was observed in hepatocellular carcinoma and indicated poor prognosis (Nguyen et al., 2020); however, investigation of dysregulation of tyrosine metabolism pathways in OSCC is lacking. This evidence concerns the gene FAH and hepatocellular carcinoma.